FDA’s 2021 Clinical Trial Regulatory Plan Focuses on Diversity, Complex Design, Drug Development Tools
March 31, 2021
The FDA’s plan for regulating clinical trials in 2021 will focus on increasing participant diversity, encouraging complex and innovative trial designs, and qualifying new drug development tools.